JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janulis, M.
Right arrow Articles by Schultz, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janulis, M.
Right arrow Articles by Schultz, R. M.

J Biol Chem, Vol. 274, Issue 2, 801-813, January 8, 1999

Role of Mitogen-activated Protein Kinases and c-Jun/AP-1 trans-Activating Activity in the Regulation of Protease mRNAs and the Malignant Phenotype in NIH 3T3 Fibroblasts

Mark JanulisDagger , Simone Silberman, Anar AmbegaokarDagger , J. Silvio Gutkindparallel , and Richard M. SchultzDagger

From the Dagger  Department of Molecular and Cellular Biochemistry and the  Department of Pathology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153 and the parallel  Molecular Signaling Unit, Laboratory of Cellular Development and Oncology, NIDR, National Institutes of Health, Bethesda, Maryland 20892

Ras activates a multitude of downstream activities with roles in cellular proliferation, invasion and metastasis, differentiation, and programmed cell death. In this work we have evaluated the requirement of extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal kinase kinase (JNKK), and c-Jun/AP-1 activities in transformation and extracellular matrix invasion of ras oncogene expressing NIH 3T3 fibroblasts by expressing stable mutant genes that constitutively inhibit these activities. Whereas the inhibition of ERK activity reverts the transformed and invasive phenotype, the inhibition of the JNK pathway and AP-1 trans-activating activities by JNKK[K129R] and c-Jun(TAM67) had no effect on the ability of the ras oncogene-expressing cells to grow in soft agar or invade Matrigel basement membrane. Thus an elevated JNK activity and/or c-Jun/AP-1 trans-activating activity are not absolute requirements for ras transformation or invasion through basement membrane, and the dependence on AP-1 activity for transformation is cell-specific. However, inhibition of JNK kinase (JNKK) in ras-transformed cells with normally elevated JNK activity switches the protease-dependent invasive phenotype from a urokinase plasminogen activator (uPA)-dependent to a cathepsin L (CL)-dependent invasive phenotype. Conversely, treatment of ras-transformed cells of low constitutive JNK activity with the JNK stimulator, anisomycin, converts the protease mRNA levels from those characteristic of a CL-dependent to a uPA-dependent phenotype. These protease phenotypes can be duplicated in untransformed NIH 3T3 cells that express platelet-derived growth factor receptors and m1 muscarinic receptors that selectively stimulate the ERK or JNK pathways, respectively. It is concluded that high ERK activity is required for both protease phenotypes, whereas the JNK pathway and c-Jun/AP-1 activity are not required for transformation but regulate a switch between uPA and CL protease phenotypes in both transformed and untransformed cells. In ras-transformed NIH 3T3 fibroblasts, the uPA- and CL-dependent protease phenotypes are redundant in their ability to invade through basement membrane.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Fu, J. A. Thompson, and L. A. Bach
Promotion of Cancer Cell Migration: AN INSULIN-LIKE GROWTH FACTOR (IGF)-INDEPENDENT ACTION OF IGF-BINDING PROTEIN-6
J. Biol. Chem., August 3, 2007; 282(31): 22298 - 22306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Silletti, M. Yebra, B. Perez, V. Cirulli, M. McMahon, and A. M. P. Montgomery
Extracellular Signal-regulated Kinase (ERK)-dependent Gene Expression Contributes to L1 Cell Adhesion Molecule-dependent Motility and Invasion
J. Biol. Chem., July 9, 2004; 279(28): 28880 - 28888.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Benasciutti, G. Pages, O. Kenzior, W. Folk, F. Blasi, and M. P. Crippa
MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription
Blood, July 1, 2004; 104(1): 256 - 262.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kielosto, P. Nummela, R. Katainen, V. Leaner, M. J. Birrer, and E. Holtta
Reversible Regulation of the Transformed Phenotype of Ornithine Decarboxylase- and Ras-Overexpressing Cells by Dominant-Negative Mutants of c-Jun
Cancer Res., June 1, 2004; 64(11): 3772 - 3779.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Qi, J. Tang, R. Pramanik, R. M. Schultz, S. Shirasawa, T. Sasazuki, J. Han, and G. Chen
p38 MAPK Activation Selectively Induces Cell Death in K-ras-mutated Human Colon Cancer Cells through Regulation of Vitamin D Receptor
J. Biol. Chem., May 21, 2004; 279(21): 22138 - 22144.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. A. Scott, J. K. Vass, E. K. Parkinson, D. A. F. Gillespie, J. N. Winnie, and B. W. Ozanne
Invasion of Normal Human Fibroblasts Induced by v-Fos Is Independent of Proliferation, Immortalization, and the Tumor Suppressors p16INK4a and p53
Mol. Cell. Biol., February 15, 2004; 24(4): 1540 - 1559.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Marinissen, J.-M. Servitja, S. Offermanns, M. I. Simon, and J. S. Gutkind
Thrombin Protease-activated Receptor-1 Signals through Gq- and G13-initiated MAPK Cascades Regulating c-Jun Expression to Induce Cell Transformation
J. Biol. Chem., November 21, 2003; 278(47): 46814 - 46825.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M.-S. Kim, E.-J. Lee, H.-R. C. Kim, and A. Moon
p38 Kinase Is a Key Signaling Molecule for H-Ras-induced Cell Motility and Invasive Phenotype in Human Breast Epithelial Cells
Cancer Res., September 1, 2003; 63(17): 5454 - 5461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Reunanen, S.-P. Li, M. Ahonen, M. Foschi, J. Han, and V.-M. Kahari
Activation of p38alpha MAPK Enhances Collagenase-1 (Matrix Metalloproteinase (MMP)-1) and Stromelysin-1 (MMP-3) Expression by mRNA Stabilization
J. Biol. Chem., August 23, 2002; 277(35): 32360 - 32368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Qi, R. Pramanik, J. Wang, R. M. Schultz, R. K. Maitra, J. Han, H. F. DeLuca, and G. Chen
The p38 and JNK Pathways Cooperate to trans-Activate Vitamin D Receptor via c-Jun/AP-1 and Sensitize Human Breast Cancer Cells to Vitamin D3-induced Growth Inhibition
J. Biol. Chem., July 12, 2002; 277(29): 25884 - 25892.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. J. Tobin, K. Foitzik, T. Reinheckel, L. Mecklenburg, V. A. Botchkarev, C. Peters, and R. Paus
The Lysosomal Protease Cathepsin L Is an Important Regulator of Keratinocyte and Melanocyte Differentiation During Hair Follicle Morphogenesis and Cycling
Am. J. Pathol., May 1, 2002; 160(5): 1807 - 1821.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Szpaderska and A. Frankfater
An Intracellular Form of Cathepsin B Contributes to Invasiveness in Cancer
Cancer Res., April 1, 2001; 61(8): 3493 - 3500.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. S. Duesbery, J. Resau, C. P. Webb, S. Koochekpour, H.-M. Koo, S. H. Leppla, and G. F. Vande Woude
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways
PNAS, March 16, 2001; (2001) 61031898.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
M. Chiariello, M. J. Marinissen, and J. S. Gutkind
Multiple Mitogen-Activated Protein Kinase Signaling Pathways Connect the Cot Oncoprotein to the c-jun Promoter and to Cellular Transformation
Mol. Cell. Biol., March 1, 2000; 20(5): 1747 - 1758.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. Xiao and W. Lang
A Dominant Role for the c-Jun NH2-Terminal Kinase in Oncogenic Ras-induced Morphologic Transformation of Human Lung Carcinoma Cells
Cancer Res., January 1, 2000; 60(2): 400 - 408.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Chiarugi, M. L. Taddei, P. Cirri, D. Talini, F. Buricchi, G. Camici, G. Manao, G. Raugei, and G. Ramponi
Low Molecular Weight Protein-tyrosine Phosphatase Controls the Rate and the Strength of NIH-3T3 Cells Adhesion through Its Phosphorylation on Tyrosine 131 or 132
J. Biol. Chem., November 22, 2000; 275(48): 37619 - 37627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Atienza, M. Suh, I. Xenarios, R. Landgraf, and J. Colicelli
Human ERK1 Induces Filamentous Growth and Cell Wall Remodeling Pathways in Saccharomyces cerevisiae
J. Biol. Chem., June 30, 2000; 275(27): 20638 - 20646.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. S. Duesbery, J. Resau, C. P. Webb, S. Koochekpour, H.-M. Koo, S. H. Leppla, and G. F. Vande Woude
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways
PNAS, March 27, 2001; 98(7): 4089 - 4094.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.